GENE.L

UBS Global Gender Equality UCITS ETF USD accUBS
AUM$184.1M
Expense Ratio0.20%
NAV$1864.60
Holdings104
InceptionDec 19, 2017

Price Chart

Key Statistics

Previous Close

Day Range

N/A

52-Week Range

N/A

Avg Volume

Dividend Yield

Expense Ratio

0.20%

AUM

$184.1M

Shares Outstanding

Sector Breakdown

SectorWeight %
Financial Services24.11%
Healthcare14.49%
Consumer Defensive11.11%
Consumer Cyclical10.75%
Utilities8.12%
Communication Services7.78%
Real Estate6.77%
Technology6.04%
Industrials5.43%
Basic Materials5.41%

Country Allocation

CountryWeight %
United States47.53%
United Kingdom11.95%
Australia9.08%
France8.59%
Norway4.53%
Spain4.06%
Canada2.38%
Switzerland2.14%
Belgium1.22%
Sweden1.20%
Italy1.16%
Japan1.16%
Netherlands1.09%
Singapore0.97%
Germany0.96%
Ireland0.82%
Denmark0.65%
New Zealand0.54%

Fund Information

Issuer
UBS
Inception Date
Dec 19, 2017
Description
The fund generally invests in the Solactive Equileap Global Gender Equality 100 Leaders Net Total Return Index. The relative weightings of the companies correspond to their weightings in the index.The investment objective is to replicate the price and return performance of the Solactive Equileap Global Gender Equality 100 Leaders Net Total Return Index net of fees. The stock exchange price may differ from the net asset value.The fund is passively managed.

Similar ETFs

SymbolNameAUMExpense RatioHoldings
VEAVanguard FTSE Developed Markets ETF$287.00B0.03%3,873
VTVVanguard Value ETF$227.40B0.03%331
IEFAiShares Core MSCI EAFE ETF$172.91B0.07%2,631
IJRiShares Core S&P Small-Cap ETF$90.48B0.06%650
VYMVanguard High Dividend Yield ETF$88.50B0.04%589

The UBS Global Gender Equality UCITS ETF USD acc (GENE.L) is an exchange-traded fund issued by UBS that launched on Dec 19, 2017. It currently manages $184.1M in assets under management. The fund charges an expense ratio of 0.20%. The fund holds 104 securities in its portfolio. It falls under the Financial Services category.

Top 10 holdings represent 14.1% of the fund

RankSymbolNameWeight %SharesMarket Value
1AAALCOA CORP1.76%53,095$3.3M
2KEYSKEYSIGHT TECHNOLOGIES IN1.59%10,318$2.9M
3SSE.LSSE PLC1.51%105,489$2.8M
4MRKMERCK & CO. INC.1.39%21,919$2.6M
5GSK.LGSK PLC1.33%119,669$2.5M
6DOWDOW INC1.33%72,576$2.5M
7JNJJOHNSON & JOHNSON1.32%10,068$2.5M
8YAR.OLYARA INTERNATIONAL ASA1.31%4,930$2.4M
9NYTNEW YORK TIMES CO-A1.30%30,487$2.4M
10BIIBBIOGEN INC1.26%12,382$2.3M
11EIXEDISON INTERNATIONAL1.24%32,207$2.3M
12GMGENERAL MOTORS CO1.23%30,393$2.3M
13NG.LNATIONAL GRID PLC1.23%168,711$2.3M
14NOVN.SWNOVARTIS AG-REG1.23%18,632$2.3M
15AZN.LASTRAZENECA PLC1.22%15,442$2.3M
Page 1 of 3

Detailed Returns

PeriodReturnETFCat. Avgvs Avg
1D

Moving Averages

20-Day MA

50-Day MA

200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

Current Price

52-Week Low

Current Yield

Annual Dividend

Frequency

Last Ex-Date

Dividends

No dividend data available for this ETF.

Category Comparison

MetricGENE.LFinancial Services(781 ETFs)
Fund Info
Expense Ratio0.20%0.67%
AUM$184.1M$3.06B
Dividend Yield4.62%
Avg Volume1.4M
Holdings104279
Performance
1-Month Return-4.97%
6-Month Return+1.69%
YTD Return+0.09%
1-Year Return+14.53%

Compare with Another ETF

Search for an ETF to compare with GENE.L: